Peptide record

TPDB41123

GE18 Anticancer standard
18 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB41123
GE18
Anticancer
Cancer-related peptides
CancerPPD 2.0
standard
No
A 18-aa standard natural anticancer peptide sequence curated from CancerPPD 2.0, with an available 3D structural model.
Sequence
GAGIVVASIDTGVRVSHE
Physicochemical Analysis
C75H127N23O26
NCQLKMFPWY
V
1766.97
5.22
2
2
8
-1
4.77
0.622
118.89
Mammalian: 30 hour Yeast: >20 hour E.coli: >10 hour
0
0.00
3
Residue Composition
number
2
A
1
R
0
N
1
D
0
C
1
E
0
Q
3
G
1
H
2
I
0
L
0
K
0
M
0
F
0
P
2
S
1
T
0
W
0
Y
4
V
Amino Acid Distribution
A: 2 R: 1 N: 0 D: 1 C: 0 E: 1 Q: 0 G: 3 H: 1 I: 2 L: 0 K: 0 M: 0 F: 0 P: 0 S: 2 T: 1 W: 0 Y: 0 V: 4
Chemical Descriptors
18
C75H127N23O26
1766.97
5.22
-1
4.77
0.622
Free
L
Linear
Free
Antimicrobial
Aphanomyces invadans
Evidence Records 1 records
Evidence 1 Activity

Activity

IC50
IC50 = 35.34 µM
Anticancer
35.34 µM

Target

Breast Cancer
MCF-7
Breast

Assay & Model

MTT assay
24-h

Source & Reference

CancerPPD 2.0
CancerPPD2
2023

Other

Source Activity Label Source Definition
Anticancer
CancerPPD 2.0 manually curated experimentally verified anticancer peptide/protein annotation.